In addition, deletion of the receptor was beneficial in a tauopathy mouse model [12] and A2AR antagonists were protective in both the APPswe/PS1dE9 [13] and the triple 3×Tg-AD transgenic AD models [14]. This evidence concerns the gene ADORA2A and Alzheimer disease.